Page last updated: 2024-09-04

atazanavir and HIV

atazanavir has been researched along with HIV in 2 studies

*HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brieger, M; Furfine, ES; Hazen, RJ; Kaldor, I; Miller, JF; Reynolds, D; Sherrill, RG; Spaltenstein, A1
Arvidsson, PI; Govender, P; Govender, T; Honarparvar, B; Kruger, HG; Maguire, GE; Makatini, MM; Petzold, K; Sayed, Y; Soliman, ME; Sriharsha, SN1

Other Studies

2 other study(ies) available for atazanavir and HIV

ArticleYear
Novel P1 chain-extended HIV protease inhibitors possessing potent anti-HIV activity and remarkable inverse antiviral resistance profiles.
    Bioorganic & medicinal chemistry letters, 2005, Aug-01, Volume: 15, Issue:15

    Topics: Animals; Anti-HIV Agents; Dogs; Drug Resistance, Multiple, Viral; HIV; HIV Protease Inhibitors; Inhibitory Concentration 50; Mutation; Rats; Structure-Activity Relationship; Virus Replication

2005
Pentacycloundecane-based inhibitors of wild-type C-South African HIV-protease.
    Bioorganic & medicinal chemistry letters, 2011, Apr-15, Volume: 21, Issue:8

    Topics: Alkanes; Binding Sites; Catalytic Domain; Computer Simulation; Genotype; HIV; HIV Protease; HIV Protease Inhibitors; Humans; South Africa

2011